ArticleJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2026
Platelet-rich plasma versus granulocyte colony-stimulating factor in addressing recurrent implantation failure: A randomized, double-blind clinical trial.
Article in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The aim of the study is to evaluate the effect of platelet-rich plasma (PRP) versus granulocyte colony-stimulating factor in addressing recurrent implantation failure. Materials and Methods: Fifty patients were randomly assigned to two treatment groups: PRP and granulocyte colony-stimulating factor (GCSF). All patients were followed up to 12 weeks after implantation. The rate of positive pregnancy tests (chemical pregnancy), implantation rate (clinical pregnancy), and pregnancy reaching 12 weeks old (ongoing pregnancy) in these two groups was compared. Results: Biochemical pregnancy, gestational sac formation, fetal heart formation, and 12-week pregnancy occurred in 6 (24%), 6 (24%), 6 (24%), and 5 women (20%) in the PRP group and occurred in 7 women (28%), 5 women (20%), 5 women (20%), and 5 women (20%) in the GCSF group. There was no statistically significant difference regarding biochemical pregnancy, gestational sac formation, fertile heart formation, and 12-week-old pregnancy between study groups ( Conclusion: Our study showed no difference in the efficacy of plasma-rich platelets and GCSFs in treating recurrent implantation failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.